Polpharma CEO warns of the risks to pharmaceutical sector

Polpharma CEO Sebastian Szymanek warns that without changes to regulations, the Polish pharmaceutical sector may have to soon import the most important prescription drugs from other countries. "Poland, like the whole of Europe, in recent decades has become dependent on the import of active substances from Asia, where it was simply cheaper,” he told in an interview with Puls Biznesu.